2010
DOI: 10.1111/j.1742-7843.2010.00603.x
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Basic Fibroblast Growth Factor on Hippocampal Cholinergic Neurons in a Rodent Model of Ischaemic Encephalopathy

Abstract: Ischaemic encephalopathy (IE) is a debilitating condition resulting from stroke that can lead to impaired learning and memory related to damage of cholinergic neurons in the hippocampus. The present study used an animal model of IE to test the hypothesis that treatment with basic fibroblast growth factor (bFGF) can reduce cognitive symptoms of IE by increasing the number of cholinergic neurons in the CA region of the hippocampus. The animal model of IE was created surgically by double ligation of the bilateral… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0
2

Year Published

2011
2011
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 18 publications
(10 citation statements)
references
References 25 publications
0
7
0
2
Order By: Relevance
“…All animals in the sham group were subjected to laminectomy alone. For bFGF injection after SCI, recombinant human bFGF, purchased from Sigma Millipore, was injected subcutaneously near the back wound at a dose of 80 g/kg at 30 min after injury (Ye et al, 2016), as described in previous studies that the subcutaneous injection of bFGF can cross the blood-brain barrier (Tao et al, 1996;Wagner et al, 1999;Ye et al, 2010) and effectively improved the functional recovery and increased the survival of neurons in a rat model of SCI (H. Y. Zhang et al, 2013a,b;Ye et al, 2016).…”
Section: Methodsmentioning
confidence: 99%
“…All animals in the sham group were subjected to laminectomy alone. For bFGF injection after SCI, recombinant human bFGF, purchased from Sigma Millipore, was injected subcutaneously near the back wound at a dose of 80 g/kg at 30 min after injury (Ye et al, 2016), as described in previous studies that the subcutaneous injection of bFGF can cross the blood-brain barrier (Tao et al, 1996;Wagner et al, 1999;Ye et al, 2010) and effectively improved the functional recovery and increased the survival of neurons in a rat model of SCI (H. Y. Zhang et al, 2013a,b;Ye et al, 2016).…”
Section: Methodsmentioning
confidence: 99%
“…37 Treatment with neurotrophic factors (ie, basic fibroblast growth factor) enhances cognitive function in an ischemic model of ischemic encephalopathy by increasing the number of cholinergic neurons in the CA region of the hippocampus. 37 Interestingly, several cell-based therapies, such as the administration of exogenous endothelial progenitor cells, might increase the level of a number of growth factors secreted by those cells. Recently, Sobrino et al 38 showed that citicoline treatment may mobilize endothelial progenitor cells from bone marrow of stroke patients, thus improving functional recovery after acute ischemic stroke.…”
Section: Citicoline In Stroke and Cognitive Declinementioning
confidence: 99%
“…Chronic cerebral hypoperfusion induced by LBCCA is shown to result in hypoxia and ischemia in the brain, leading to impaired BBB [ 32 ]. A number of studies have shown that impaired BBB is often associated with depression [ 33 , 34 ].…”
Section: Discussionmentioning
confidence: 99%